-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2021 to 2023.
- Amylyx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $819K, a 98.5% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $92.1M.
- Amylyx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$239M, a 415% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)